Via binding to the 3′-UTRs of FOS-like 2 (FOSL2), miR-143 can negatively regulate FOSL2 expression, suggesting that the UCA1/miR-143 axis may have potential therapeutic value for the treatment of cisplatin resistance in ovarian cancer patients (Li Z. et al., 2019). Here, FOSL2 is linked to ovarian cancer.